目次

TABLE OF CONTENTS

1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.2.1 KEY INCLUSIONS & EXCLUSIONS
1.3 RESEARCH SCOPE
1.3.1 SEGMENTS COVERED
1.3.2 GEOGRAPHIC SCOPE
1.3.3 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY USED FOR THE STUDY
1.5 MAJOR MARKET STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.6.1 RECESSION IMPACT

2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA SOURCES
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
2.2 MARKET SIZE ESTIMATION METHODOLOGY
2.3 MARKET SHARE ESTIMATION METHODOLOGY
2.4 MARKET BREAK DOWN AND DATA TRIANGULATION
2.5 RESEARCH ASSUMPTIONS
2.6 RESEARCH LIMITATIONS
2.6.1 SCOPE RELATED LIMITATIONS
2.6.2 METHODOLOGY RELATED LIMITATIONS
2.7 RISK ASSESSMENT
2.8 RECESSION IMPACT ASSESSMENT APPROACH

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

5 MARKET OVERVIEW
5.1 MARKET DYNAMICS
5.1.1 MAJOR DRIVERS
5.1.2 KEY RESTRAINTS
5.1.3 KEY GROWTH OPPORTUNITIES
5.1.4 INDUSTRY-SPECIFIC CHALLENGES
5.2 TARIFF AND REGULATORY LANDSCAPE
5.2.1 TARIFF RELATED TO MINIMALLY INVASIVE MEDICAL ROBOTICS, IMAGING VISUALISATION SYSTEMS & SURGICAL INSTRUMENTS
5.2.2 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
5.2.3 REGULATORY TRENDS, BY REGION
5.3 VALUE CHAIN ANALYSIS
5.4 SUPPLY CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
5.6 TECHNOLOGY ANALYSIS
5.6.1 KEY TECHNOLOGIES
5.6.1.1 LAPAROSCOPY
5.6.1.2 ABLATION
5.6.1.3 ELECTROSURGERY
5.6.1.2 POWERED SURGICAL PRODUCT
5.6.2 COMPLEMENTARY TECHNOLOGIES
5.6.2.1 ROBOTIC SURGERY
5.6.2.2 DIGITAL SOLUTION (AI, IOT)
5.6.2.3 MEDICAL/ SURGICAL IMAGING
5.6.3 ADJECENT TECHNOLOGIES
5.6.3.1 ENDOSCOPE
5.6.3.2 SURGICAL IMPLANTS
5.7 REIMBURSEMENT SCENARIO
5.8 INVESTMENT AND FUNDING SCENARIO
5.9 TRADE DATA
5.10 PATENT DATA
5.11 PORTER’S FIVE FORCE ANALYSIS
5.12 PRICING ANALYSIS
5.12.1 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
5.12.2 AVERAGE SELLING PRICE TREND, BY REGION
5.13 CASE STUDY ANALYSIS
5.14 KEY CONFERENCES AND EVENTS IN 2024-25
5.15 KEY STAKEHOLDERS & BUYING CRITERIA
5.15.1 KEY STAKEHOLDERS IN THE BUYING PROCESS
5.15.2 BUYING CRITERIA
5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS
5.17 CUSTOMER UNMET NEEDS IN MINIMALLY INVASIVE MEDICAL ROBOTICS, IMAGING VISUALISATION SYSTEMS & SURGICAL INSTRUMENTS MARKET

6 MINIMALLY INVASIVE SURGERY MARKET, BY PRODUCT (USD MILLION; 2021—2029) *
6.1 SURGICAL DEVICES
6.1.1 HANDHELD INSTRUMENTS
6.1.1.1 Tubular Retractor
6.1.1.2 Dilator
6.1.1.3 Suturing Instruments
6.1.1.4 Probes
6.1.1.5 Laser fiber devices
6.1.2 GUIDING DEVICES
6.1.2.1 Guiding catheters
6.1.2.2 Guidewires
6.1.3 INFLATION SYSTEMS
6.1.3.1 Balloon Catheters
6.1.3.2 Balloon inflation system
6.1.4 LAPAROSCOPY DEVICES
6.1.4.1 Laparoscope
6.1.4.2 Trocar and Cannula
6.1.4.3 RASP (Robotic- Assisted Simple Prostatectomy)
6.1.4.4 Graspers and Dissectors
6.2 IMAGING & VISUALIZATION SYSTEMS
6.2.1 ULTRASOUND
6.2.2 CT IMAGING
6.2.3 MRI IMAGING
6.2.4 X-RAY IMAGING
6.2.5 VISUALIZATION SYSTEMS
6.3 ELECTROSURGICAL DEVICES
6.3.1 ELECTROSURGICAL GENERATORS & ACCESSORIES
6.3.2 ELECTROCAUTERY DEVICES
6.4 ENDOSCOPY DEVICES
6.4.1 RIGID ENDOSCOPES
6.4.2 FLEXIBLE ENDOSCOPES
6.4.3 DIAGNOSTIC ENDOSCOPES
6.5 MEDICAL ROBOTICS
6.5.1 ROBOTIC SYSTEMS
6.5.2 ROBOTIC INSTRUMENTS
6.5.4 ROBOTIC SOFTWARES & SERVICES

7 MINIMALLY INVASIVE SUREGRY MARKET, BY APPLICATION (USD MILLION; 2021—2029) *
7.1 CARDIO-THORACIC SURGERY
7.2 VASCULAR SURGERY
7.3 NEUROLOGICAL SURGERY
7.4 ENT & RESPIRATORY SURGERY
7.5 COSMETIC SURGERY
7.6 GASTROINTESTINAL & ABDOMINAL SURGERY
7.7 GYNECOLOGICAL SURGERY
7.8 UROLOGICAL SURGERY
7.9 ORTHOPEDIC SURGERY
7.10 ONCOLOGY SURGERY
7.11 DENTAL SURGERY
7.12 OTHERS

8 MINIMALLY INVASIVE SURGERY MARKET, BY END USER (USD MILLION; 2021—2029) *
8.1 HOSPITALS, CLINICS & ABLATION CENTERS
8.2 AMBULATORY SURGICAL CENTERS
8.3 ORTHOPEDIC, EMERGENCY & TRAUMA CENTERS
8.3 OTHERS

9 MINIMALLY INVASIVE SURGERY MARKET, BY REGION (USD MILLION; 2021—2029)*
9.1 NORTH AMERICA
9.1.1 RECESSION IMPACT
9.1.2 US
9.1.3 CANADA
9.2 EUROPE
9.2.1 RECESSION IMPACT
9.2.2 GERMANY
9.2.3 UK
9.2.4 FRANCE
9.2.5 ITALY
9.2.6 SPAIN
9.2.7 REST OF EUROPE
9.3 ASIA-PACIFIC
9.3.1 RECESSION IMPACT
9.3.2 JAPAN
9.3.3 CHINA
9.3.4 INDIA
9.3.5 SOUTH KOREA
9.3.6 AUSTRALIA
9.3.7 REST OF ASIA-PACIFIC
9.4 LATIN AMERICA
9.4.1 RECESSION IMPACT
9.4.2 BRAZIL
9.4.3 MEXICO
9.4.4 REST OF LATIN AMERICA
9.5 MIDDLE EAST AND AFRICA
9.5.1 RECESSION IMPACT
9.4.3 GCC COUNTRIES

10 COMPETITIVE LANDSCAPE
10.1 OVERVIEW
10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
10.3 REVENUE ANALYSIS OF KEY PLAYERS (2023)
10.4 MARKET SHARE ANALYSIS FOR TOP 5 GLOBAL PLAYERS (IN TERMS OF %REVENUE, IN 2022)
10.4.1 MINIMALLY INVASIVE MEDICAL ROBOTICS
10.4.2 IMAGING VISUALISATION SYSTEMS
10.4.3 SURGICAL INSTRUMENTS
10.4.4 ELECTROSURGICAL DEVICES
10.4.5 ENDOSCOPY DEVICES
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
10.5.5.1 COMPANY FOOTPRINT
10.5.5.2 REGION FOOTPRINT
10.5.5.3 PRODUCT FOOTPRINT
10.5.5.4 APPLICATION FOOTPRINT
10.5.5.5 END-USER FOOTPRINT
10.6 COMPANY EVALUATION MATRIX: STARTUPS/ SMES, 2023
10.6.1 PROGRESSIVE COMPANIES
10.6.2 RESPONSIVE COMPANIES
10.6.3 DYNAMIC COMPANIES
10.6.4 STARTING BLOCKS
10.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
10.6.5.1 DETAILED LIST OF KEY STARTUPS/SMES
10.6.5.2 COMPETITIVE BENCHMARKING OF KEY STARTUPS/SMES
10.7 COMPETITIVE SCENARIO AND TRENDS (2021-2023)
10.7.1 PRODUCT LAUNCHES
10.7.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS
10.7.3 MERGERS & ACQUISITIONS
10.7.4 EXPANSIONS
10.8 PRODUCT COMPARISON
10.9 COMPANY VALUATION AND FINANCIAL METRICS

11 COMPANY PROFILES**
(Business Overview, Products Offered, Industry-specific Developments for 2021-2023)***
11.1 KEY COMPANIES
11.1.1 MEDTRONIC, PLC
11.1.2 JOHNSONS & JOHNSONS
11.1.3 ABBOTT LABORATORIES
11.1.4 STRYKER CORPORATION
11.1.5 BECTON, DICKINSON AND COMPANY
11.1.6 SIEMENS HEALTHINEERS
11.1.7 SMITH & NEPHEW
11.1.8 PHILIPS HEALTHCARE
11.1.9 FUJIFILM CORPORATION
11.1.10 COOPERSURGICAL INC.
11.1.11 GE HEALTHCARE
11.1.12 BOSTON SCIENTIFIC
11.1.13 ABBOTT LABORATORIES
11.1.14 TELEFLEX
11.1.15 B. BRAUN MELSUNGEN
11.2 OTHER PLAYERS
11.2.1 COOK MEDICAL
11.2.2 ZIMMER BIOMET HOLDINGS
11.2.3 OLYMPUS CORPORATION
11.2.4 INTUITIVE SURGICAL INC.
11.2.5 KARL STORZ
11.2.6 EDWARDS LIFESCIENCES CORP
11.2.7 NIPRO CORPORATION
11.2.8 GETINGE AB
11.2.9 INTEGRA LIFESCIENCES
11.2.10 NUVASIVE INC.
11.2.11 CONMED CORPORATION
11.2.12 APPLIED MEDICAL
11.2.13 ACCURAY
11.2.14 RICHARD WOLF
11.2.15 ATEC SPINE, INC.

12 APPENDIX